DNA Diagonostics: Technologies and Global Markets
July 01, 2008
Wellesley, Mass—According to a new technical market research report, DNA DIAGNOSTICS: TECHNOLOGIES AND GLOBAL MARKETS (BIO063A) from BCC Research (www.bccresearch.com), the global market for DNA diagnostics technology is expected to be worth $10.6 billion in 2008. This will increase to over $20.1 billion by 2013, a compound annual growth rate (CAGR) of 13.7%.
The market is broken down into applications of DNA microarrays, polymerase chain reaction-based assays (PCR), in-situ hybridization diagnostics (ISH), and lab-on-a-chip diagnostics (LOAC). Of these, PCR-based assays will claim the largest share of the market in 2008 with a value of $5.4 billion. This segment should reach $9.5 billion in 2013, for a CAGR of 11.9%.
DNA microarrays represent the second largest segment, with $2.4 billion in revenue expected in 2008. This figure will grow to $4.6 billion in 2013 for a CAGR of 13.8%. ISH diagnostics will increase from $1.9 billion in 2008 to $3.9 billion in 2013, for a CAGR of 15.3%. The fastest growing segment of the DNA diagnostics market is the lab-on-a-chip market, which is expected to reach $890 million in 2008 and $2.1 billion in 2013, for a CAGR of 18.7%.
Molecular diagnostics and molecular imaging for diagnostics have benefited greatly from research since the completion of the Human Genome Project. Biomarkers are playing increasingly important roles, especially in the area of cancer research and treatment. Technologies are being used to analyze biological samples in molecular diagnostics to identify high-risk patients, predict response to therapy, and monitor patients during treatment.
Source: BCC Research
DNA Diagnostics: Technologies and Global Markets( BIO063A )
Publish Date: Jun 2008
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Cell Biology
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development
Reports from Cell Biology
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum